1.82
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLS Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.91
Aprire:
$1.91
Volume 24 ore:
4.53M
Relative Volume:
1.55
Capitalizzazione di mercato:
$191.64M
Reddito:
-
Utile/perdita netta:
$-37.34M
Rapporto P/E:
-1.3382
EPS:
-1.36
Flusso di cassa netto:
$-36.91M
1 W Prestazione:
-8.54%
1M Prestazione:
+13.04%
6M Prestazione:
+17.42%
1 anno Prestazione:
+54.24%
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
Nome
Sellas Life Sciences Group Inc
Settore
Industria
Telefono
(646) 200-5278
Indirizzo
7 TIMES SQUARE, NEW YORK, NY
Confronta SLS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
SLS
Sellas Life Sciences Group Inc
|
1.82 | 281.61M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-07-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-11-01 | Iniziato | Oppenheimer | Outperform |
| 2018-04-02 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-19 | Aggiornamento | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc Borsa (SLS) Ultime notizie
Understanding SELLAS Life Sciences Group Inc.’s price movementWeekly Stock Recap & Weekly Breakout Watchlists - newser.com
SELLAS Life Sciences Group Inc. stock prediction for this weekJuly 2025 Highlights & Real-Time Market Sentiment Alerts - newser.com
Is SELLAS Life Sciences Group Inc. showing signs of accumulation2025 Price Momentum & Reliable Volume Spike Trade Alerts - newser.com
Using economic indicators to assess SELLAS Life Sciences Group Inc. potential2025 Technical Patterns & Consistent Profit Trade Alerts - newser.com
Can SELLAS Life Sciences Group Inc. (RXK3) stock hold up in economic slowdownTrade Risk Assessment & High Win Rate Trade Alerts - newser.com
SELLAS Life Sciences Group Inc. stock trend forecastJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Should you wait for a breakout in SELLAS Life Sciences Group Inc.Market Activity Summary & Technical Entry and Exit Alerts - newser.com
What technical models suggest about SELLAS Life Sciences Group Inc.’s comeback2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Does SELLAS Life Sciences Group Inc. show high probability of reboundQuarterly Portfolio Report & Long-Term Investment Growth Plans - newser.com
SELLAS Life Sciences Group Inc. stock outlook for YEAR2025 Growth vs Value & AI Enhanced Trading Signals - newser.com
Is SELLAS Life Sciences Group Inc. reversing from oversold territory2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com
Is SELLAS Life Sciences Group Inc. stock attractive for retirement portfoliosMarket Risk Analysis & Growth Focused Entry Reports - newser.com
Will SELLAS Life Sciences Group Inc. (RXK3) stock test record highs in 2025July 2025 Fed Impact & Consistent Profit Focused Trading Strategies - newser.com
Can SELLAS Life Sciences Group Inc. stock sustain revenue growthMarket Risk Summary & Safe Capital Growth Stock Tips - newser.com
How SELLAS Life Sciences Group Inc. stock valuations compare to rivalsMarket Performance Summary & AI Forecasted Entry and Exit Points - newser.com
Does SELLAS Life Sciences Group Inc. fit your quant trading model2025 Major Catalysts & Community Verified Swing Trade Signals - newser.com
Why Is SELLAS Life Sciences Stock Falling Today? - MSN
How institutional ownership impacts SELLAS Life Sciences Group Inc. stockInflation Watch & Breakout Confirmation Alerts - newser.com
Transcript : SELLAS Life Sciences Group, Inc.Special Call - MarketScreener
Sellas Life Sciences Group Inc. (SLS) Advances Cancer Pipeline with $31M Funding and Upcoming R&D Showcase - Insider Monkey
Sellas Life Sciences Group Inc Azioni (SLS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):